Ipamorelin is the most prescribed GH secretagogue in the biohacking space. Its only published human efficacy trial enrolled 114 people and failed to meet its primary endpoint at P=0.15. The development program Effects of tirzepatide, a dual GIP and GLP 1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke prone spontaneously hypertensive rats Hypertension Research Ipamorelin Research Peptide Alpha Carbon Labs Ipamorelin Vs Sermorelin: Decoding The Differences In Peptide Therapies